Eli Lilly Q3 Non-GAAP Earnings Fall, Revenue Rises; Lowers Full-Year EPS Guidance

Eli Lilly and Company (LLY) reported Q3 non-GAAP earnings Thursday of $0.10 per diluted share, down from $1.98 a year earlier. Analysts polled by Capital IQ expected $0.67. Revenue for the quarter ended Sept. 30 was $9.50 billion, up from $6.94 billion a year earlier. Analysts surveyed by Capital IQ expected $8.99 billion. The company lowered 2023 guidance for non-GAAP earnings to $6.50 and $6.70 per share, from $9.70 to $9.90 previously. Analysts surveyed by Capital IQ expect $7.97. The drug maker also continues to expect revenue of $33.4 billion and $33.9 billion. Analysts surveyed by Capital IQ expect $33.42 billion.

Eli Lilly Q3 Non-GAAP Earnings Fall, Revenue Rises; Lowers Full-Year EPS Guidance Read Post »

S&P Global Global Posts Higher Revenue

S&P Global posted higher sales and earnings for the third quarter, lifted by strength across the data-and-analytics company. The New York-based credit-ratings and data provider reported a profit of $742 million, or $2.33 a share, up from $608 million, or $1.84 a share, in the same quarter a year ago. Stripping out one-time items, adjusted earnings were $3.21 a share. Analysts surveyed by FactSet expected adjusted earnings of $3.04 a share. Sales rose 8% to $3.08 billion. Analysts surveyed by FactSet expected $3.03 billion. Sales rose across all of the company’s businesses, excluding its engineering-solutions business, which it has agreed to sell for $975 million to private-equity buyers. S&P Global’s ratings business recorded a 20% rise in sales and its market-intelligence unit posted an 8% increase in sales.

S&P Global Global Posts Higher Revenue Read Post »

Starbucks Executive Said China’s Average Weekly Sales Grew Quarter Over Quarter In Line With Our Guidance Of Low To Mid Single Digit Growth

Starbucks Executive Said China’s Average Weekly Sales Grew Quarter Over Quarter In Line With Our Guidance Of Low To Mid Single Digit Growth -Conf Call。

Starbucks Executive Said China’s Average Weekly Sales Grew Quarter Over Quarter In Line With Our Guidance Of Low To Mid Single Digit Growth Read Post »

CFRA Keeps Hold Rating On Shares Of Roku, Inc.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: ROKU benefits on the pivot to video streaming from pay TV. The bull case scenario seems to be a low threshold of just reaching positive EBITDA in 2024. Assuming a high risk premium, we keep our target price at $75 on a forward P/S of 2.48x vs. media peers’ 2.0x average. We narrow our LPS in 2023 by $1.30 to -$3.50 and reduce 2024’s by $0.40 to -$2.40. ROKU posted a normalized loss of -$0.33 (GAAP loss of -$2.33) in Q3 2023 and adj. EBITDA was +43.4M, with guidance of +$10.0M in Q4 2023, which ROKU is steadfast on reaching positive EBITDA for the full year 2024. We forecast total revenue of $3.44B in 2023 and $3.82B in 2024. Platform unit realized 18% Y/Y revenue growth (86%

CFRA Keeps Hold Rating On Shares Of Roku, Inc. Read Post »

Scroll to Top